This year at the European Congress of Radiology (ECR), FUJIFILM will showcase its evolving portfolio of medical informatics and Enterprise Imaging innovations, by presenting ARTIFICIAL INTELLIGENCE (AI) and enhancing.
Fujifilm's ARTIFICIAL INTELLIGENCE development initiative willharness the power of AI to enhance its imaging and informatics healthcare Synapse portfolio whichincludes Synapse PACS, Synapse Cardiovascular and Synapse VNA among other solutions. In anincreasingly complex healthcare environment with larger datasets and rising demand for highquality care, AI will have the potential to change the practice of medicine. The AI revolution isunderway and with its long history of innovation, Fujifilm is at the forefront of development to refinethis disruptive technology for medical imaging and healthcare informatics. Fujifilm AI can beexperienced with the support of product specialist at booth.
Fujifilm Medical Informatics Synapse platform to be showcased at ECR includes also thecomprehensive medical informatics and enterprise imaging portfolio:
Experts and product specialists are available for product demonstration and to create taylor made solutions for any healthcare structure.
1: Syncro-Med is a Company owned and subjected to management and coordination of Fujifilm Italia S.p.A.
Experts and product specialists are available for product and images demonstration.
Fujifilm Healthcare @ECR 2018, Vienna March 1/4, Expo X5, Booth #503.
Luana Porfido, Medical Systems Europe Marketing and Communication Manager:
Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation.